financetom
Business
financetom
/
Business
/
ServiceNow Insider Sold Shares Worth $1,003,873, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ServiceNow Insider Sold Shares Worth $1,003,873, According to a Recent SEC Filing
Sep 3, 2025 1:00 AM

03:41 AM EDT, 09/03/2025 (MT Newswires) -- Anita M Sands, Director, on August 29, 2025, sold 1,097 shares in ServiceNow ( NOW ) for $1,003,873. Following the Form 4 filing with the SEC, Sands has control over a total of 9,307 common shares of the company, with 9,307 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1373715/000158984925000004/xslF345X05/wk-form4_1756860481.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UBS's rescue of Credit Suisse has created new risks for Switzerland, OECD says
UBS's rescue of Credit Suisse has created new risks for Switzerland, OECD says
Mar 14, 2024
* Credit Suisse takeover poses new risks for Swiss economy - OECD * Swiss economy should be able to absorb resulting job losses * OECD raises competition concerns in Swiss banking * Swiss economic growth seen at 0.9% in 2024, 1.4% in 2025 ZURICH, March 14 (Reuters) - UBS's rescue takeover of Credit Suisse a year ago has created new...
Mirum Pharmaceuticals Says FDA Approved Familial Intrahepatic Cholestasis Treatment
Mirum Pharmaceuticals Says FDA Approved Familial Intrahepatic Cholestasis Treatment
Mar 14, 2024
05:08 AM EDT, 03/14/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said late Wednesday the US Food and Drug Administration has approved its Livmarli product for the treatment of cholestatic pruritus in patients who are at least five years old with progressive familial intrahepatic cholestasis. Progressive familial intrahepatic cholestasis is a genetic disorder that leads to progressive liver disease,...
Mesoblast Raises AU$97 Million From Entitlement Offer, Institutional Placement
Mesoblast Raises AU$97 Million From Entitlement Offer, Institutional Placement
Mar 14, 2024
05:22 AM EDT, 03/14/2024 (MT Newswires) -- Mesoblast (MESO) said late Wednesday it has completed an entitlement offer and an institutional placement of securities raising total gross proceeds of $97 million Australian dollars ($64.2 million). In addition, the company said its Chief Medical Officer Eric Rose subscribed for AU$1.5 million worth of additional shares, subject to shareholder approval. Price: 2.55,...
Lithium Americas to get $2.26 bln loan from US DOE for Nevada project
Lithium Americas to get $2.26 bln loan from US DOE for Nevada project
Mar 14, 2024
March 14 (Reuters) - The U.S. Department of Energy has granted Lithium Americas ( LAC ) a conditional commitment loan of $2.26 billion to finance the construction of processing facilities at its Thacker Pass project in Nevada, the company said on Thursday. Once the loan is closed, the company expects to start major construction in the second half of this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved